B+
Bull case
25%
Probability
Target price
$14.00
Analysis reference price unavailable
Analysis 2026-05-04 · RankAlpha Sentiment Codex
BDSX
BiodesixFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
If the Q1 2026 release confirms another clean revenue-growth quarter, maintains the FY2026 revenue framework introduced with Q4 2025 results, and shows cash usage continuing to moderate, BDSX can keep a speculative recovery case alive from a depressed market cap base.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
As of May 4, 2026, the actual Q1 2026 earnings release was not yet confirmed on the company quarterly-results page, so the surprise and guidance read-through remain open.
Momentum
96
Value
37
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $11.50 · Bull $14.00 · Bear $8.00Analysis 2026-05-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $34.00
Why
Momentum96 · Δ7d +0.8
Value37 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • As of May 4, 2026, the actual Q1 2026 earnings release was not yet confirmed on the company quarterly-results page, so the surprise and guidance read-through remain open.
- • If Q4 2025 margin and Adjusted EBITDA gains do not hold into 2026, the re-rating case weakens quickly.
- • If the May 4, 2026 print shows growth deceleration, weaker gross margin, renewed EBITDA slippage, or heavier financing needs, the stock likely loses the main support behind the earlier cautious-positive setup because current valuation still depends heavily on execution credibility.
Catalyst clock
2026-05-04
May 4, 2026 earnings release is still the immediate gating event
Lead driver: Value · See fundamentals
Momentum
96
9% active weight
Current posture
7d trendFlat
Δ7d
+0.8
Δ21d
+0.2
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade F. Momentum 96.3 / Value 36.6 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-05-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2026-05-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$245.31M
Beta
0.65
Shares Out
10.55M
P/E (TTM) · Derived
-5.0
P/S (TTM)
0.62
P/FCF (TTM) · Derived
-9.92
Rev YoY
+34.2%
EPS YoY
-54.8%
Gross Margin
+82.5%
Op Margin
-20.0%
Net Debt
$53.77M
Current Ratio
2.85
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data